Detection of metabolites in biological samples using prokaryotic genetic circuits
A synthetic genetic construct with three modules enables simultaneous and immediate detection and quantification of Phe and Tyr in various samples, addressing the limitations of existing methods by providing accurate and user-friendly results across different types of samples.
Patent Information
- Application Number
- PCT/IB2026/051328
- Authority / Receiving Office
- WO · WO
- Patent Type
- Applications
- Current Assignee / Owner
- Filing Date
- 2026-02-11
- Publication Date
- 2026-11-12
AI Technical Summary
Existing methods for the detection and quantification of phenylalanine (Phe) and tyrosine (Tyr) are not user-friendly, require trained professionals, and are not applicable across different types of samples, including biological samples and food, without the need for a cold chain.
A synthetic genetic construct comprising three modules: a first module with the TyrR protein, a second module using the ptyrP promoter, and a third module with a STAR system, allowing for simultaneous and immediate detection and quantification of Phe and Tyr in various samples.
The biosensor provides accurate, robust, and user-friendly detection and quantification of Phe and Tyr in biological fluids and food samples without requiring a cold chain or sophisticated equipment, suitable for applications such as neonatal screening and environmental monitoring.
Smart Images

Figure IMGF000018_0001 
Figure IMGF000011_0001_TABLE 
Figure IMGF000011_0002_TABLE
Abstract
Description
[0001] DETECTION OF METABOLITES IN BIOLOGICAL SAMPLES USING PROKARYOTIC GENETIC CIRCUITS
[0002] TECHNICAL FIELD
[0003] This disclosure refers to the general field of biotechnology, particularly to biotechnology applied to the detection and quantification of biological molecules using genetic circuit biosensors.
[0004] DESCRIPTION OF THE STATE OF THE ART
[0005] Phenylalanine (Phe) is an essential amino acid found in proteins as L-phenylalanine (LFA). Biochemically, it is characterized as an aromatic amino acid with a side chain containing a benzene ring. Phe is closely related to tyrosine (Tyr), a non-essential amino acid that, unlike Phe, is characterized by the presence of a hydroxyl group on its aromatic ring.
[0006] Phenylketonuria (PKU) is a hereditary genetic disorder related to amino acid metabolism, which can lead to elevated phenylalanine (Phe) levels as a result of a deficiency in the enzyme phenylalanine hydroxylase (PAH), which plays a key role in the hydroxylation of Phe to tyrosine (Tyr). Biochemically, PKU is characterized by the accumulation of Phe and a deficiency of Tyr. Excess Phe can be metabolized to phenylpyruvate (PPA), a phenylketone compound present in the urine of individuals with PKU, from which the disorder derives its name. Phe concentration is therefore an important marker for the diagnosis of PKU (A. Bone, AK Kuehl, AF Angelino. A neuropsychiatric perspective of phenylketonuria I: overview of phenylketonuria and its neuropsychiatric sequelae. Psychosomatics, 53: 2012.).
[0007] The accumulation of phenylalanine (Phe) and polyphosphate (PPA) affects the central nervous system, causing severe intellectual disability, developmental delay, microcephaly, and seizures—symptoms that, in untreated cases, can appear as early as one year of age. Therefore, early diagnosis is crucial for the correct treatment of this condition, and eliminating foods rich in Phe is the conventional approach, at least until brain maturation is complete.
[0008] Early detection of phenylalanine (Phe) levels in neonates' blood is essential for the diagnosis of phenylketonuria (PKU). Furthermore, continuous Phe monitoring allows for dietary control of foods rich in this amino acid. Given that a high Phe / Tyr ratio is commonly observed in patients with PKU, continuous measurement and quantification of both Phe and Tyr can be useful for maintaining strict control over dietary Phe intake. In addition, Phe / Tyr ratios have been used to effectively confirm the diagnosis of PKU and hyperphenylalaninemia (Chieh Lin, et al., Transcription factor-based biosensor for detection of phenylalanine and tyrosine in urine for diagnosis of phenylketonuria, Analytica Chimica Acta, Volume 1041, 2018, Pages 108-113, https: / / doi.org / 10.1016 / j.aca.2018.08.053).
[0009] Additionally, the detection of Phe / Tyr is also very useful in other applications unrelated to phenylketonuria, such as:
[0010] Research in neuroscience and biochemistry
[0011] Neurotransmitter synthesis: Tyr is an essential precursor of important neurotransmitters such as dopamine, norepinephrine, and epinephrine. In neuroscience studies, Tyr quantification is crucial for investigating neurological and psychiatric disorders and understanding the regulation of neurotransmitter synthesis and its impact on behavior and brain function. Accurate Tyr measurement helps to better understand these metabolic pathways and their relationship to various clinical conditions (Bulacu, D., Panaite, F., & Oystaeyen, F. (2005). Generalized Diagonal Crossed Products and Smash Products for Quasi-Hopf Algebras. Applications).
[0012] Monitoring of wastewater treatment processes
[0013] Activated sludge processes: In environmental engineering, Tyr is used as a marker of microbial activity in activated sludge processes. Tyr quantification is essential for monitoring and optimizing these biological processes, ensuring efficient and effective wastewater treatment. This monitoring allows for adjusting process conditions to maximize contaminant degradation and maintain system stability (Kabouris, J., & Georgakakos, A. (1996). Parameter and state estimation of the activated sludge process — II. Applications. DOI: 10.1016 / 0043-1354(95)00326-6).
[0014] Development of analytical methods in chromatography
[0015] High-performance liquid chromatography (HPLC): HPLC is a widely used technique for measuring Phe and Tyr in biological and food samples. This technique allows the development of precise and robust analytical methods for quantifying these amino acids, which is crucial for biomedical research and quality control in the food industry. Measurement accuracy ensures the reliability of results and the ability to detect minute variations in the concentrations of these amino acids (Snyder, LR, Dolan, J., & Lommen, D. (1990). High-performance liquid chromatographic computer simulation based on a restricted multi-parameter approach: II. Applications. DOI: 10.1016 / S0021-9673(01)88936-6).
[0016] Development of advanced materials
[0017] Biocompatible polymers: Phenoxyethanol (Phe) and tyrosine (Tyr) are being investigated in the development of new biocompatible materials. These amino acids can be key components in the synthesis of polymers that mimic biological structures. The precise quantification of these amino acids is crucial for optimizing material properties and functionality in biomedical applications, such as the manufacture of medical devices and artificial tissues (Frischinger, I., Muturi, P., & Dirlikov, S. (1994). Two-Phase Interpenetrating Epoxy Thermosets That Contain Epoxidized Triglyceride Oils: Part II. Applications. DOI: 10.1021 / BA-1994-0239.CH026).
[0018] Evaluation of analytical methods and quality control
[0019] Methods of analysis of food and supplements: In the food and supplement industry, the quantification of Phe and Tyr is essential to ensure that products meet quality and safety specifications. Methods such as HPLC are used to verify the content of these amino acids in food products and nutritional supplements, ensuring that consumers receive safe and effective products (Snyder, LR, Dolan, J., & Lommen, D. (1990). High-performance liquid chromatographic computer simulation based on a restricted multi-parameter approach: II. Applications. DOI: 10.1016 / S0021-9673(01)88936-6).
[0020] These applications highlight the importance of Phe and Tyr quantification in various scientific and technological areas, from medicine to the food and advanced materials industries.
[0021] In this regard, several publications describe methods for detecting Phe and Tyr. For example, the document "Transcription factor-based biosensor for detection of phenylalanine and tyrosine in urine for diagnosis of phenylketonuria" (Chieh Lin, et al., 2018) discloses a quantitative method for detecting Phe and Tyr for the diagnosis of phenylketonuria. The method described in this document is based on a whole-cell biosensor for the quantification of Phe and Tyr through the expression of red and green fluorescent proteins and can be used in human urine samples. In particular, this document focuses on the transcriptional regulation of TyrR in E. coli and proposes the use of E. coli strains carrying a plasmid containing the PtyrP-gfp and ParoF-rfp promoters.These promoters are activated in the presence of the amino acids Phe and Tyr in the analyzed samples. In the case of Phe, an upward colorimetric change is observed; that is, a higher concentration of Phe results in greater fluorescence emission. In contrast, the presence of Tyr in the Tyr promoter leads to repression of the gene expression controlled by the promoter, resulting in a loss of the fluorescent signal. The genetic construct described here has been designed to increase the reporter signal through the use of antisense RNAs controlled by the Tyr promoter. This is advantageous because detecting an increase in signal is more readily apparent than detecting a decrease.
[0022] Additionally, the document "Engineering ligand-specific biosensors for aromatic amino acids and neurochemicals" (Rottinghaus AG, Xi C, Amrofell MB, Yi H, Moon TS. Engineering ligand-specific biosensors for aromatic amino acids and neurochemicals. Cell Syst. 2022 Mar 16;13(3):204-214.e4. doi: 10.1016 / j.cels.2021.10.006) refers to biosensor systems that recognize aromatic amino acids or neurochemicals. These biosensor systems have improved selectivity and sensitivity for the specific identification of Phe, Tyr, phenylethylamine, and tyramine. In particular, this document discloses sensors for the aromatic metabolites Phe, Tyr, PEA and Trypta using E. coli Nissle 1917 (EcN) as a host, and teaches two sensor systems: the TyrR sensor (Phe and Tyr) and the TynA-FeaR sensor system (aromatic amines).The ligand selectivity and sensitivity of these sensors was achieved by rationally selecting and individually mutating amino acids in TyrR, TynA, and FeaR, generating multiple small libraries.
[0023] Another example is the paper “Screening of an Escherichia coli promoter library for a phenylalanine biosensor” (Mahr R, von Boeselager RF, Wiechert J, Frunzke J. Screening of an Escherichia coli promoter library for a phenylalanine biosensor. Appl Microbiol Biotechnol. 2016 Aug;100(15):6739-6753. doi: 10.1007 / s00253-016-7575-8), which describes a strategy for selecting promoter libraries for biosensor design. Specifically, this paper discusses the fusion of the E. coli gfpmut2 promoter with galactose- and L-phenylalanine-sensitive promoters, enhanced through alternating rounds of positive and negative selection using fluorescence-activated cell sorting (FACS). This document also notes that the mtr promoter, which encodes a specific L-tryptophan transporter, can be used to construct an L-phenylalanine biosensor.
[0024] Despite various publications on this topic, there remains a need to develop an alternative method for the parallel and immediate detection and quantification of phenylalanine (Phe) and tyrosine (Tyr), independent of the cold chain, and easy to use, thus not requiring operation by highly trained professionals. Furthermore, none of the available technologies are known to be applicable for the detection and quantification of Phe and Tyr in different types of samples, including biological samples and other types such as flour, infant formula, and food.
[0025] BRIEF DESCRIPTION
[0026] This disclosure relates to a biosensor consisting of a synthetic genetic construct or circuit for the detection and quantification of Phe and Tyr. This biosensor can operate, among others, in a model prokaryotic organism. The genetic construct consists of three modules: a first module comprising the sequence of the regulatory protein tyrR, which responds selectively to Phe and Tyr to activate or repress gene expression, depending on the amino acid present; a second module that responds to Phe; and a third module, which in turn comprises three submodules and responds to Tyr.
[0027] The biosensor allows for the simultaneous and immediate detection and quantification of Phe and Tyr. This technology is effective, robust, and user-friendly for detecting and quantifying these metabolites in various biological samples, such as biological fluids or other materials (flours, formulas, food, etc.).
[0028] BRIEF DESCRIPTION OF THE FIGURES FIG. 1 Components of the MeDIUB-PKU circuit
[0029] Biological components describing the design and structure of the MeDIUB-PKU biosensor. The figure shows the division of the three modules that make up the system, namely:
[0030] 1. R MODULE. Regulator module comprising two sequences:
[0031] (i) The TyrR protein, which acts as a central regulator of the response, which in the presence of Phe will form a dimer and in the presence of Tyr a hexamer; and
[0032] (ii) The STAR Regulator (Reg-STAR) which is an antisense RNA sequence capable of regulating reporter expression under the control of the STAR sequence, which is found as part of the T module.
[0033] 2. T MODULE. Composed of the paroF promoter, which is duplicated, with each promoter replica independently controlling two antisense RNA molecules (asReg-STAR and asGFP), and a minimal constitutive promoter J23119, which controls the STAR sequence that, in turn, controls the transcription of the reporter, in this case, a green fluorescent protein or GFP. Interchangeable transcription terminators are located at the ends of these constructs.
[0034] 3. MODULE F. This module consists of the ptyrP promoter, a reporter under the control of this promoter which in this case is a red fluorescent protein, which can be exchanged, and a transcription terminator.
[0035] FIG. 2 Functioning of the TA module. Inactive state of the system: the TyR protein is found as a monomer in the medium without the presence of Tyr, therefore, the paroF promoters are in full activity expressing both antisense molecules, which bind to the Reg-STAR molecule and the reporter mRNA, which allows the signal to remain inactive.
[0036] B. Active system: In the presence of Tyr, the tyrR protein forms a hexamer, which is located within the paroF promoter, silencing it and thus inhibiting the production of antisense RNA molecules. In this way, the existing repression on fluorescence expression is released, causing Reg-STAR to linearize to the STAR sequence in the transcript and, in turn, allowing the expression of the green reporter.
[0037] FIG. 3 Operation of module F
[0038] In its inactive state, the tyrR protein exists as an inactive monomer, and transcription is not activated. In its active state, the TyrR protein, upon binding with the amino acid Phe, assumes a dimer conformation, which allows it to bind to the ptyrP promoter and activate its expression, resulting in the expression of the red protein.
[0039] FIG. 4
[0040] A. Phe concentrations were evaluated in a range of 0 to 500 μM, obtaining a linear correlation between the fluorescence emitted by the efordRed marker and the Phe concentrations. The figure represents the biosensor's response curves when exposed to increasing concentrations of Phe. Increasing fluorescence is observed, proportional to the amount of Phe present.
[0041] B. The linear range of the biosensor is shown, highlighting its accuracy and applicability for quantitative measurements in the clinically relevant range. The linear detection range was clearly defined between 0 and 500 μM.
[0042] FIG. 5
[0043] A. Presents the biosensor response curves to increasing concentrations of Tyr, demonstrating the functionality of the STAR system and its interaction with asRNA. The response curve showed a directly proportional relationship between the concentration of Tyr and the fluorescent signal emitted by amilGFP.
[0044] B. Shows the linear range of the biosensor, highlighting its ability to detect Tyr at concentrations relevant for clinical diagnostics and metabolic monitoring. The linear detection range was established between 0 and 100 μM, allowing for precise measurements in relevant biological samples.
[0045] DETAILED DESCRIPTION
[0046] This disclosure relates to a biosensor consisting of a synthetic genetic construct for the simultaneous detection and quantification of Phe and Tyr.
[0047] For the purposes of this disclosure, a biosensor is defined as a biologically based construct, such as DNA sequences designed to respond detectably to the presence of a specific molecule. This response is manifested through the expression of a reporter molecule, such as a fluorescent protein, which allows for the visual or quantifiable detection of this interaction.
[0048] For the purposes of this disclosure, a genetic construct is understood to be an assembly of DNA that has been designed and built to include various genetic elements, such as promoters, terminators, regulatory sequences and genes of interest, and RNA regulatory sequences, organized functionally, in order to introduce new functions or characteristics into a biological system.
[0049] For the purposes of this disclosure, a biological system corresponds to an environment in which biological processes take place, which may include living organisms such as bacteria, plants, animals, or cell-free systems that replicate certain biological conditions for gene expression.
[0050] In one embodiment of the present invention, the construct comprises one or more of the following elements:
[0051] • Promoters: DNA sequences that control the initiation of gene transcription. They act as switches that can turn gene expression on or off. • Terminators: DNA sequences that signal the end of gene transcription. They ensure that transcription terminates at the correct location, providing stability to the messenger RNA produced.
[0052] • Regulatory sequences: DNA elements that can influence gene expression by interacting with regulatory proteins. These sequences can be enhancers, which increase transcription, or repressors, which decrease transcription.
[0053] • Genes of interest: DNA sequences that code for proteins or RNA with specific desired functions. These genes are the primary target of the genetic construct, as they provide the desired function or characteristic.
[0054] For the purposes of the present invention, the genetic construct can function in both living organisms and cell-free systems to modify gene expression and phenotype in a controlled and predictable manner.
[0055] For the purposes of the present invention, the synthetic genetic construct corresponds to a catalytic biosensor, that is, one whose purpose is to induce a reaction (chemical or biophysical) for the measurement of biological or chemical parameters. In a particular embodiment of the invention, the construct allows the detection of Phe and Tyr.
[0056] For the purposes of the present invention, a genetic module is understood to be a functional unit within a genetic construct, designed for the transcription of one or more RNA or protein molecules. Each genetic module contains a specific sequence that enables it to perform a particular function, which is part of the overall activities carried out by the genetic construct as a whole.
[0057] The synthetic genetic construct for the detection of Phe and Tyr comprises:
[0058] a) a first receptor module, comprising the central response regulator having in the 5'>3' direction an interchangeable promoter, an interchangeable ribosome binding sequence (RBS), a TyrR protein coding sequence and an interchangeable transcription terminator;
[0059] b) a second genetic module comprising in the 5'>3' direction the ptyrP promoter sequence, an interchangeable ribosome binding sequence (RBS), an interchangeable reporter protein coding sequence, and an interchangeable transcription terminator;
[0060] c) a third genetic module comprising:
[0061] i. a first submodule comprising two parts, each comprising in the 5'>3' direction a paroF promoter sequence; an antisense RNA sequence; a bacterial MicF sequence and a terminator;
[0062] ii. a second submodule comprising in the 5'>3' direction a sequence of an interchangeable constitutive promoter, the STAR AD1.A5 sequence of the Enterococcus faecalis pDA1 plasmid, an interchangeable RBS, an interchangeable reporter, and an interchangeable transcription terminator, wherein the transcription of the reporter is controlled by the STAR sequence;
[0063] iii. a third submodule comprising in the 5'>3' direction a sequence of an interchangeable constitutive promoter, the STAR AD1.S5 sequence of the Enterococcus faecalis pDA1 plasmid and an interchangeable transcription terminator.
[0064] First genetic module
[0065] The first module of the receptor construct comprises the central response regulator comprising, in the 5'>3' direction, an interchangeable promoter, an interchangeable ribosome binding sequence (RBS), a TyrR protein coding sequence, and an interchangeable transcription terminator.
[0066] For the purposes of the present invention, the function of the receptor, which comprises the central regulator of the response, is to act as a binding molecule between the molecule to be measured (Phe or Tyr) and the DNA sequence at which a response will be activated or repressed upon binding. In particular embodiments of the invention, the coding sequence of the TyrR protein is selected from the sequences identified in the NCBI with Gene ID Nos. 945879, 9734074, 57837695, or 45569595.
[0067] For the purposes of the present invention, an interchangeable promoter is defined as a DNA sequence that initiates or promotes the transcription of a specific DNA sequence. Its function is to act as a signal recognized by the cellular machinery to begin messenger RNA synthesis. The interchangeable promoter is selected from natural or synthetic promoters that are activated by the μ70 factor subunit. In another embodiment of the invention, the interchangeable promoter corresponds to the sequences SEQ ID NOs: 1 to 4 (Table 1).
[0068] Table 1. Interchangeable promoter sequences.
[0069]
[0070] For the purposes of the present invention, an interchangeable ribosome-binding sequence (RBS) is defined as a regulatory sequence in the mRNA upstream of the start codon. This element is also known as the Shine-Dalgarno sequence, and its function is to be the recognition site of the 16S rRNA of the small ribosomal subunit, positioning the ribosome in the correct open reading frame of the mRNA.
[0071] In particular embodiments of the invention, the interchangeable ribosome binding sequence (RBS) is selected from SEQ ID NOs: 5 to 46. In another embodiment of the invention, the RBS is SEQ ID NO: 5 or 6. In another embodiment of the invention, the RBS is a sequence with 70%, 80%, 85%, 90%, 95%, or 99% identity of SEQ ID NOs: 5 to 46 (Table 2).
[0072] Table 2. Exchangeable ribosome binding sequences (RBS).
[0073]
[0074]
[0075]
[0076]
[0077] For the purposes of the present invention, a transcription terminator is understood to be the DNA sequence that indicates the end of transcription. Its function is to ensure that transcription stops at the appropriate location and that the messenger RNA has the correct sequence for subsequent activity.
[0078] In particular embodiments of the invention, the transcription terminator is selected from the group corresponding to an intrinsic (RHO-independent) transcription terminator constitutive of the natural or synthetic gammaproteobacterial genome. For the purposes of the invention, the transcription terminator is selected from the coding genes listed in Table 3.
[0079] Table 3. Transcription terminator coding genes.
[0080]
[0081] |
[0082]
[0083] For the purposes of the present invention, the first genetic module comprises the sequence of the regulatory protein TyrR, which is part of the Tyr operon that regulates the central metabolism of aromatic amino acids such as Phe, Tyr and tryptophan within prokaryotic organisms such as the bacterium E. coli, or other bacterial models such as Staphylococcus aureus or Bacillus subtilis.
[0084] For the purposes of this disclosure, the TyrR protein exhibits different conformations that allow it to respond differentially to any of the three aromatic amino acids, selectively binding to regulatory DNA sequences within different promoters such as ptyrP or paroF, which control the specific response in the presence of Phe or Tyr, respectively. The TyrR protein forms a dimer structure (in the presence of Phe) or a hexamer structure (in the presence of Tyr), activating or repressing the expression of the gene controlled by this sequence, respectively. For the purposes of this invention, the TyrR protein functions as the general transducer of the genetic construct.
[0085] Second genetic module
[0086] For the purposes of the present invention, the second genetic module or module 2 comprises, in the 5'>3' direction, a ptyrP promoter sequence, an interchangeable ribosome binding sequence (RBS), an interchangeable reporter protein coding sequence, and an interchangeable transcription terminator.
[0087] For the purposes of the present invention, a ptyrP promoter is defined as a DNA sequence in which the TyrR protein can bind as a phenylalanine dimer to the Tyr boxes and trigger transcription.
[0088] The ptyrP promoter controls a reporter gene, which is selected from a gene that codes for red fluorescent protein, RFP, GFP, meleRFP, meffblue, AmilGFP, AmilRFP, amilCP, meleCFP, GFP and other reporter proteins from cnidarians such as corals and jellyfish.
[0089] For the purposes of the present invention, an interchangeable reporter protein is defined as a protein used in experiments to monitor and measure genetic or cellular activity. These proteins are used as visual or functional markers to study gene regulation and expression. In one embodiment of the invention, the reporter protein is selected from fluorescent red, RFP, GFP, meleRFP, meffblue, AmilGFP, AmilRFP, amilCP, meleCFP, GFP, and other reporter proteins from cnidarians such as corals and jellyfish. In one embodiment of the invention, the reporter protein is AmilGFP, meleRFP, or efordRed.
[0090] In the present invention, the second module of the genetic construct is designed to respond to the presence of Phe. The TyrR protein, encoded in module 1, selectively activates the ptyrP promoter upon binding to Phe, which controls a reporter gene. Thus, the presence of Phe acts as an inducer of the system controlled by the TyrR protein.
[0091] Third genetic module
[0092] The third genetic module is composed of a system of proteins that bind to molecules and DNA, but also antisense RNA molecules for greater control of the system.
[0093] The third module of the genetic construct functions by responding to the presence of Tyr. This module operates through the inducible interaction of different RNA molecules which, in the presence of Tyr, cause activation of the reporter of this system, while in its absence, they keep the signal switched off. For the purposes of the present invention, module 3 comprises three submodules that interact with each other in a constitutive and inducible manner. The third genetic module comprises a first submodule, a second submodule, and a third submodule. i. A first submodule comprising two parts, each comprising, in the 5' to 3' direction, a paroF promoter sequence; an antisense RNA sequence; a bacterial MicF sequence; and a terminator;
[0094] ii. a second submodule comprising in the 5'>3' direction a sequence of an interchangeable constitutive promoter, the STAR AD1.A5 sequence of the Enterococcus faecalis pDA1 plasmid, an interchangeable RBS, an interchangeable reporter, and an interchangeable transcription terminator, wherein the transcription of the reporter is controlled by the STAR sequence;
[0095] iii. a third submodule comprising in the 5'>3' direction a sequence of an interchangeable constitutive promoter, the STAR AD1.S5 sequence of the pDA1 plasmid of E. feacalis and an interchangeable transcription terminator.
[0096] For the purposes of the present invention, the paroF promoter is defined as a DNA sequence in which the TyrR protein can bind as a hexamer with Tyr to the Tyr boxes and repress transcription.
[0097] For the purposes of the present invention, an antisense RNA is understood to be an RNA molecule that is complementary to a specific messenger RNA (mRNA) sequence. By binding to its complementary mRNA, the antisense RNA can inhibit the translation of the mRNA into protein or promote its degradation. In one embodiment of the invention, the antisense RNA sequence of the first submodule of the third genetic module binds to the RBS and the first codons corresponding to the reporter coding sequence.
[0098] Generally, a bacterial MicF sequence is defined as an RNA sequence within messenger RNA that signals the rapid degradation of the complex to which this RNA is bound. For the purposes of the present invention, the MicF sequence is found in antisense RNAs, and this molecule recruits the HFQ complex, which mediates degradation by RNases. In one embodiment of the invention, the bacterial MicF sequence corresponds to SEQ ID NO: 47 (TCATTTCTGAATGTCTGTTTACCCCTATTTCAACCGGATGCCTCGCATTCGG
[0099]
[0100] For the purposes of the present invention, the sequence STAR AD1. A5 is the sequence of the pDAl plasmid of E. feacalis.
[0101] For the purposes of the present invention, the sequence STAR AD1. S5 is the sequence of the pDAl plasmid of E. feacalis.
[0102] Submodule 1 is composed, in the 5' to 3' direction, of a paroF promoter sequence, an antisense RNA sequence (asReg-STAR or asGFP), a MicF sequence, and a terminator. This promoter-to-terminator design is duplicated in this submodule to express both antisense RNA sequences independently. This allows for the expression of both asReg-STAR and asGFP molecules with the same expression kinetics, as they are controlled by the same promoter. When these sequences are constitutively expressed in the absence of Tyr, they maintain the repression of the submodule 2 reporter through base pairing and MicF-mediated degradation. When Tyr is present, the tyrR protein forms a hexamer and selectively binds to the paroF promoter sequence, repressing the transcription of the asReg-STAR and asGFP antisense RNAs and releasing the reporter repression of the second submodule.
[0103] Submodule 2 of the third module allows reporter transcription to be controlled by the STAR sequence, which functions as an early transcription terminator, forming a stem-and-loop structure that prevents reporter expression controlled by this sequence.
[0104] In one particular embodiment of this disclosure, the regulatory sequence STAR interacts with an early STAR terminator within the third module. The binding of these sequences linearizes the stem-loop secondary structure produced by this sequence. This constitutively activates the transcription of the interchangeable reporter (GFP) placed under the control of the STAR sequence in the third module.
[0105] For the purposes of this disclosure, submodules 1, 2, and 3 of the third module, as well as their regulatory elements, have been designed as interchangeable parts to facilitate the system engineering process. For the purposes of this invention, the genetic construct can operate within a prokaryotic organism or in cell-free systems. This implies its operation using the cellular machinery of organisms such as E. coli, but without the need for endogenous presence in the organism; that is, in a TX-TL reaction, where the transcription (TX) and translation (TL) systems of genes are not subject to the restrictions required by cell culture-based processes. In one embodiment of the present invention, the model prokaryotic organism can be, among others, E. coli, Staphylococcus aureus, or Bacillus subtilis.In certain applications, the use of cell-free systems offers significant advantages, as they provide a gene expression platform that is easy to use for protein synthesis, enzyme engineering, and synthetic biology processes under open reaction conditions. This allows for easy manipulation and direct downstream processing of the synthesized proteins or enzymes.
[0106] Applications
[0107] For the purposes of the present invention, the genetic construct allows the simultaneous detection of Phe and Tyr since both modules function in parallel in an orthogonal manner and are capable of giving a visual response together and separately in a colorimetric manner.
[0108] In one embodiment of the present invention, the genetic construct allows the detection of Phe and Tyr in a large number of analytes, including biological samples such as blood samples, urine, dried blood collected on filter paper, serum, feces, sweat, mucus, biopsies, bronchial aspirates, spinal aspirate, breast milk, buccal swabs, vaginal swabs, nasal swabs, vaginal swabs, rectal swabs, urethral swabs, seminal fluid, chorionic fluid, amniotic fluid, pleural fluid, among others, as well as food samples such as flours, formula milks, processed foods such as: dairy products, cereals, nutritional supplements, and / or fresh foods such as: meat, vegetables or fruits.
[0109] For the purposes of the present invention, the reagents or strains of the genetic construct are lyophilized, so it functions completely independently of an absolute cold chain. For the purposes of the present invention, the genetic construct for the detection of Phe and Tyr allows for simple operation, such that it does not require only trained professionals to use the system, since it is a simplified system that only requires placing the sample and observing a colorimetric response. Additionally, the genetic construct for the detection of Phe and Tyr of the present invention does not require sophisticated equipment for its use.
[0110] In a particular embodiment of the present invention, the genetic construct can be included in a device, diagnostic kit, immunochromatographic detection cassette, ELISA technique, etc.
[0111] In one particular embodiment of the present invention, the genetic construct can be included in a kit for performing quantitative enzyme tests, useful for neonatal screening for phenylketonuria (PKU). The construct included in this kit allows for the quantification of neonatal Phe concentrations outside of normal values in dried blood spot samples on filter paper.
[0112] In addition, the construct can be in other modalities such as "point of care" devices, such as a medical instrument and a sports instrument, such as a reaction strip, inside reaction tubes, inside glass capillaries, coupled to a microfluidic system, as a cell-free reaction in tubes, as an emulsion reaction, as a droplet reaction (dropler PCR), as a TX-TL reaction diagnostic kit.
[0113] Other applications of the genetic construct of the present disclosure include, but are not limited to, the following: neurotransmitter synthesis, monitoring of wastewater treatment processes, activated sludge processes, development of analytical methods in chromatography, high-performance liquid chromatography (HPLC), development of advanced materials, biocompatible polymers, evaluation of analytical methods and quality control, and methods for analyzing food and supplements. The present invention will be presented in detail through the following examples, which are provided for illustrative purposes only and not intended to limit its scope.
[0114] EXAMPLES EXAMPLE 1: System Design
[0115] The Tyr operon was selected as the main component of the system for the development of the genetic construct. The TyrR protein acts as the system's general transducer, as it can recognize and transmit signals in transcriptional responses. The regions where the multiple conformations of the TyrR protein bind are composed of "Tyr boxes," which are regulatory sequences arranged so that the protein can bind to different promoters specifically. The ptyrR and paroF promoters were chosen because of their ability to recognize Phe and Tyr.
[0116] The ptyrR promoter acts as a transcriptional activator, recruiting sigma factor and RNA polymerase to initiate transcription, placing the reporter (e.g., efordRed) under its control. The paroF promoter, which normally functions as a repressor, was adapted using the E. faecalis STAR system. This system allows signal transmission to induce reporter activation through the integration of antisense RNA (asRNA). Thus, the reporter (e.g., amilGFP) was placed under the control of the constitutive promoter J23119 and the STAR-regulator sequence (Reg-STAR), which is regulated by the J23105 promoter. To fine-tune reporter control under the paroF promoter, two antisense RNAs were designed that bind to the STAR-regulator and the reporter mRNA (e.g., amilGFP), thereby modulating the signal upstream in the presence of Tyr.
[0117] EXAMPLE 2: In vitro molecular assembly
[0118] Sequences and primers were used to amplify E. coli K-12 genomic sequences and reporter gene sequences. Restriction enzymes and Gibson assembly were used for cloning, and transformations into E. coli DH5a were performed using the classical chemical transformation protocol with CaCl2. To confirm assembly, restriction enzyme digestion patterns were used to verify the orientation and position of the sequences. In addition, Sanger sequencing was performed to confirm that the asRNA sequences were correct.
[0119] EXAMPLE 2. Quantification of Phe using the F module of the biosensor
[0120] The biosensor's F module was specifically designed to detect and quantify the presence of Phe in biological samples. This module utilizes the ptyrP promoter, which is activated when the TyrR protein, in its dimer form, binds to Phe. This activation induces the transcription of the reporter gene efordRed, a fluorescent marker that allows direct visualization of Phe levels via red fluorescence.
[0121] The ptyrP promoter was selected for the construction of module F due to its ability to respond directly to Phe by activating the TyrR protein. This system was assembled in E. coli and subjected to experimental validations to evaluate its sensitivity and detection range. The results showed that the system responds linearly to increasing concentrations of Phe.
[0122] As shown in FIG 4A, Phe concentrations were evaluated in a range of 0 to 500 μM, obtaining a linear correlation between the fluorescence emitted by the efordRed marker and the Phe concentrations. The sensitivity of the system was validated in the physiological range of Phe relevant for clinical applications, demonstrating its usefulness for diagnoses such as phenylketonuria (PKU).
[0123] The linear detection range was clearly defined between 0 and 500 μM, as illustrated in FIG.4B.
[0124] This module has been shown to offer a significant advantage by being highly specific for Phe, avoiding interference from other amino acids. Furthermore, the direct signal provided by efordRed eliminates the need for sophisticated equipment, making it accessible for low-cost applications and resource-constrained environments.
[0125] EXAMPLE 3. Tyr quantification using the biosensor's T module. The T module was designed to detect and quantify Tyr using an innovative approach that integrates the paroF promoter and the STAR system, with additional regulation via antisense RNA (asRNA). This design transforms the natural repressive signal of the paroF promoter into a positive signal, allowing activation of the amilGFP reporter.
[0126] The paroF promoter was chosen for its responsiveness to Tyr through the interaction of the TyrR protein in its hexameric form. To overcome its repressive nature, two antisense RNA (asRNA) molecules were incorporated, designed to block the transcription of regulatory genes when Tyr is absent. This design was complemented by the STAR system, which uses the STAR AD1.A5 sequence of the E. faecalis pDA1 plasmid to convert repressive signals into activating ones.
[0127] The tests performed showed increased fluorescence in the presence of Tyr, validating the effectiveness of the module in quantifying this amino acid.
[0128] The response curve showed a directly proportional relationship between the Tyr concentration and the fluorescent signal emitted by amilGFP (FIG 5A). The linear detection range was established between 0 and 100 μM, allowing for accurate measurements in relevant biological samples (FIG 5B).
[0129] This system is innovative in that it transforms a repressor promoter into a functional activator using RNA technology. This not only improves the system's sensitivity but also enables precise quantitative measurement without the need for complex equipment.
Claims
REIVINDICATORY CHAPTER 1. A synthetic genetic construct for the detection of phenylalanine and tyrosine comprising: a) a first receptor module, comprising the central response regulator comprising in the 5'>3' direction an interchangeable promoter, an interchangeable ribosome binding sequence (RBS), a TyrR protein coding sequence and an interchangeable transcription terminator; b) a second genetic module comprising in the 5'>3' direction the ptyrP promoter sequence, an interchangeable ribosome-binding sequence (RBS), an interchangeable reporter protein coding sequence, and an interchangeable transcription terminator; c) a third genetic module comprising: i. a first submodule comprising two parts, each comprising in the 5'>3' direction a paroF promoter sequence; an antisense RNA sequence; a bacterial MicF sequence and a terminator; ii. a second submodule comprising in the 5'>3' direction a sequence of an interchangeable constitutive promoter, the STAR AD1.A5 sequence of the Enterococcus faecalis pDA1 plasmid, an interchangeable RBS, an interchangeable reporter, and an interchangeable transcription terminator, wherein the transcription of the reporter is controlled by the STAR sequence; iii. a third submodule comprising in the 5'>3' direction a sequence of an interchangeable constitutive promoter, the STAR AD1.S5 sequence of the pDA1 plasmid of E. feacalis and an interchangeable transcription terminator.
2. The genetic construct of Claim 1 wherein the interchangeable ribosome-binding sequence (RBS) of the first, second, and third genetic module is selected from the group comprising SEQ ID NOs: 6 to 47, or a sequence with 80% identity of SEQ ID NOs: 6 to 47.
3. The genetic construct of Claim 1 wherein the interchangeable promoter sequence of the first and third genetic modules is selected from natural or synthetic promoters that are activated by the Ø70 factor subunit.
4. The genetic construct of Claim 1 wherein the interchangeable transcription terminator of the first and second modules is selected from the group corresponding to an intrinsic (RHO-independent) transcription terminator constitutive of the natural or synthetic gammaproteobacterial genome.
5. The genetic construct of Claim 1 wherein the antisense RNA sequence of the first submodule of the third genetic module is joined to the RBS and first codons corresponding to the reporter coding sequence.
